Giant Cell Tumor of Bone: Risk Factors for Recurrence

BACKGROUND: Many surgeons treat giant cell tumor of bone (GCT) with intralesional curettage. Wide resection is reserved for extensive bone destruction where joint preservation is impossible or when expendable sites (eg, fibular head) are affected. Adjuvants such as polymethylmethacrylate and phenol...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Klenke, Frank M., Wenger, Doris E., Inwards, Carrie Y., Rose, Peter S., Sim, Franklin H.
Formato: Artigo
Idioma:Inglês
Publicado: Springer-Verlag 2010
Assuntos:
Clinical Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3018195/
https://ncbi.nlm.nih.gov/pubmed/20706812
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11999-010-1501-7
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares